Articles

John Rim, the company’s former executive vice-president, has been named its new president and CEO. 

Samsung Biologics Appoints New President and CEO

The HERALD trial will involve participants 18 years and older who will receive a two-dose schedule of CVnCoV or placebo at multiple sites is Europe and Latin America.

CureVac Enrolls First Participant in COVID-19 Vaccine Candidate Trial 

The companies are entering into a license and collaboration agreement for the development and commercialization of Relay’s investigational cancer treatment, RLY-1971, a potent inhibitor of SHP2, a molecule that plays a role in cancer cell survival. 

Genentech and Relay Therapeutics Announce Potent Inhibitor Development Collaboration 

The ISPE APQ Guide: Corrective Action and Preventive Action (CAPA) System is the first in a four-part series that will address refining pharmaceutical quality and guaranteeing sustainable compliance within organizations.

ISPE Releases First Guide from its Advancing Pharmaceutical Quality Program

The company will expand its clinical supply chain services by establishing two new facilities in Rheinfelden and Weil am Rhein, Germany.

Thermo Fisher to Expand its European Clinical Supply Chain Services

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Freezers, shipping containers, and tracking systems aid distribution of COVID-19 vaccines.

New Products for the Pharma Cold Chain  

Through the acquisition, Eli Lilly will have access to Prevail’s portfolio of clinical-stage and preclinical neuroscience assets. 

Eli Lilly to Acquire Prevail Therapeutics for $1 Billion

Trixeo Aerosphere—AstraZeneca’s triple-combination COPD therapy—has been approved for use in the European Union (EU).

AstraZeneca’s COPD Treatment Gains Approval in Europe

Sterling Pharma Solutions has formed a new strategic partnership with ADC Bio.

Sterling Forms Strategic Partnership with ADC Bio

A report, launched by Takeda UK, has shown that despite the increase in media attention, COVID-19 has had little positive impact on the perception of pharmaceutical companies. 

News